References (country) | Design | Baseline characteristics mean ± SD (N) | Na intake assessment method | UNa (mg/day) Mean ± SD (N) |
Outcomes assessed |
Confounders adjusted for | Key findings |
---|---|---|---|---|---|---|---|
Devine et al. (1995); Prince et al. (1995) (Australia) |
RCT in postmenopausal women (≥ 10 years after menopause) Group 1: Ca suppl. (1 g/day) Group 2: Ca suppl. (1 g/day) + exercise programme Group 3: Placebo Group 4: ~200 mL milk/day (1 g Ca/day) N = 196 screened N = 168 randomised (42/group) Duration: 2 years |
Age: 63 (168) bw: 66 ± 10 (191) Nutrient intakes based on 4‐day weighed diet records (190): Protein: 76 ± 16 g/day Ca (food only): 805 ± 320 mg/day P: 1,269 ± 311 mg/day Energy: 1,632 ± 348 kcal/day |
Single 24‐h urine samples collected at baseline, year 1 and year 2; excretions averaged over the 2‐year period. No information on instructions to participants or on measures to check completeness of collections. |
Baseline UNa: 2,783 ± 1,081 (196) Average year 1 and 2 UNa: 3,049 ± 808 (127) |
BMD (total hip, intertrochanter, femoral neck, ultradistal ankle, lumbar spine) By DEXA at baseline, 1 year and 2 years |
Body weight, change in METs/day over the 2‐year period, average daily Ca intake |
Multiple regression analysis: Negative associations between average UNa and 2‐year change in BMD for total hip (SRC = −0.20, p = 0.002) and ultradistal ankle (SRC = −0.18, p = 0.016) |
Ilich et al. (2010) (USA) |
RCT in postmenopausal women (≥ 5 years after menopause); all supplemented with Ca (630 mg/day) and vitamin D (~ 400 IU/day) Group 1: instructed to reduce Na intake to 1,500 mg/day Group 2: usual Na intake (~ 3,000 mg/day) N = 136 randomised (68/group) N = 97 completed Duration: 3 years |
Age: 68.6 ± 7.1 (136) bw: 68.0 ± 11.3 (136) BMI: 26.0 ± 3.8 (136) Nutrient intakes based on 4‐day weighed diet records (136): Protein: 70.6 ± 18.6 g/day Ca (food only): 872 ± 365 mg/day P: 1,077 ± 351 mg/day Energy: 1,691 ± 382 kcal/day |
Single 24‐h urine samples collected every 6 months. Cumulative Na/Cr used as variable. Careful instructions to participants and use of Cr to screen for errors or incomplete collection |
Baseline UNa: 2,404 ± 963 (136) Baseline UNa/g Cr: 2,465 ± 903 (136) |
BMD (composite femur, forearm, lumbar spine, total body) By DEXA at baseline and every 6 months |
Age, height, cumulative lean and/or fat tissue, cumulative total calcium intake and cumulative modes of physical activity |
Multiple regression analysis (ITT): Positive associations between cumulative UNa/Cr and BMD at 36 months at LS (Coeff. = 5.85e−5, p = 0.056), at forearm (Coeff. = 8.12e−5, p = 0.076) and total body BMD (Coeff. = 2.81e−5, p = 0.041) |
Random‐effects regression analysis (accounting for repeated measures and missing data): Main effect of UNa in the forearm: higher UNa associated with higher BMD at baseline and subsequent time points (t = 2.63, p = 0.0089). Similar observation in the spine. No effect on total body or femoral BMD |
BMD: bone mineral density; BMI: body mass index; bw: body weight; Ca: calcium; Cr: creatinine; DEXA: dual‐energy X‐ray technology; MET: metabolic equivalent activity; IU: international unit; N: number; Na: sodium; NR: not reported; P: phosphorus; RCT: randomised controlled trial; SD: standard deviation; SRC: standardised regression coefficient; UNa: urinary sodium excretion.